<DOC>
	<DOCNO>NCT00297661</DOCNO>
	<brief_summary>Context : Sirolimus-eluting stent paclitaxel-eluting stent , compare bare-metal stent , reduce risk restenosis . It unclear whether difference safety efficacy two type drug-eluting stent . Objective : To determine difference safety efficacy sirolimus paclitaxel elute stent .</brief_summary>
	<brief_title>Sirolimus-Eluting Versus Paclitaxel-Eluting Stents Coronary Revascularization</brief_title>
	<detailed_description>Design : Randomized control , observer-blind trial compare sirolimus-eluting stent paclitaxel-eluting stent Patients : 1012 patient undergo percutaneous coronary intervention . The two group similar baseline clinical angiographic characteristic .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients either stable angina acute coronary syndrome eligible participate least one lesion stenosis least 50 percent vessel reference diameter 2.25 4.00 mm suitable stent implantation . Allergy antiplatelet drug , heparin , stainless steel , contrast agent , sirolimus , paclitaxel ; participation another coronarydevice study ; terminal illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Coronary Revascularization</keyword>
	<keyword>Sirolimus-eluting stent</keyword>
	<keyword>Paclitaxel-eluting stent</keyword>
</DOC>